Clinical and biochemical predictors of very preterm birth in twin-to-twin transfusion syndrome treated by fetoscopy

Am J Obstet Gynecol. 2011 Jan;204(1):58.e1-5. doi: 10.1016/j.ajog.2010.08.032. Epub 2010 Oct 14.

Abstract

Objective: To evaluate pre- and postoperative predictors of preterm birth in twin-to-twin transfusion syndrome treated with fetoscopic placental laser coagulation.

Study design: Prospective cohort study (n = 166) assessing cervical length (pre and postoperatively), amniotic fluid interleukin-6, serum C-reactive protein and duration of surgery. Logistic regression was used to investigate associations with preterm delivery.

Results: Preterm delivery within 7 days, before 28.0 and 32.0 weeks occurred in 4.8%, 16.8%, and 28.9%, respectively. The only significant predictor of delivery within 7 days was postoperative cervical length (odds ratio [OR], 0.5; 95% confidence interval [CI], 0.3-0.9). Concerning delivery before 32.0 weeks, preoperative cervical length (OR, 0.9; 95% CI, 0.8-1.0), and gestational age (OR, 0.8; 95% CI, 0.4-0.9) were independent risk factors but the association was weak. The presence of a single survivor after surgery was associated with a clear reduction of risk (OR, 0.3; 95% CI, 0.1-0.6). Inflammatory biomarkers and duration of surgery did not discriminate risk of prematurity.

Conclusion: No strong preoperative predictive factor of preterm birth could be identified. A single survivor was a strong protective factor of very preterm birth.

MeSH terms

  • Adult
  • Amniotic Fluid / chemistry*
  • Biomarkers / analysis
  • C-Reactive Protein / analysis*
  • Cervical Length Measurement / methods
  • Female
  • Fetofetal Transfusion / metabolism
  • Fetofetal Transfusion / surgery
  • Fetoscopy / adverse effects*
  • Fetoscopy / methods
  • Humans
  • Infant, Newborn
  • Interleukin-6 / analysis*
  • Laser Coagulation / methods
  • Logistic Models
  • Pregnancy
  • Premature Birth / blood
  • Premature Birth / diagnosis*
  • Premature Birth / etiology
  • Prospective Studies
  • Risk Factors

Substances

  • Biomarkers
  • Interleukin-6
  • C-Reactive Protein